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Statement of Problem—Porous tantalum trabecular metal has recently been incorporated in 
titanium dental implants as a new form of implant surface enhancement. However, there is little 
information on the applications of this material in implant dentistry.
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Methods—We, therefore review the current literature on the basic science and clinical uses of 
this material.
Results—Porous tantalum metal is used to improve the contact between osseous structure and 
dental implants; and therefore presumably facilitate osseointegration. Success of porous tantalum 
metal in orthopedic implants led to the incorporation of porous tantalum metal in the design of 
root-from endosseous titanium implants. The porous tantalum three-dimensional enhancement of 
titanium dental implant surface allows for combining bone ongrowth together with bone ingrowth, 
or osseoincorporation. While little is known about the biological aspect of the porous tantalum in 
the oral cavity, there seems to be several possible advantages of this implant design. This article 
reviews the biological aspects of porous tantalum enhanced titanium dental implants, in particular 
the effects of anatomical consideration and oral environment to implant designs.
Conclusions—We propose here possible clinical situations and applications for this type of 
dental implant. Advantages and disadvantages of the implants as well as needed future clinical 
studies are discussed.
It is estimated that over 26% of people, ages 65–74 in the US are edentulous.1 The number 
of edentulous people and people with significant number of missing teeth is even worse in 
the developing world. It is known that edentulism is a comorbidity to several systemic and 
oral diseases such as osteoporosis, hypertension, atherosclerosis, diabetes, cancer, etc. 2–7 
However, the underlying molecular mechanism that may lead an edentulous individual to be 
at risk for these diseases is not known. Several biological changes occur after loss of natural 
teeth. These include reduction on masticatory efficiency, altered neuronal/physiolocal 
sensation, psycological effects, alveolar bone remodeling, and changes on microflora 
composition. Complete and partial edentulism clearly reduces mechanical chewing function 
and esthetics. Edentulism and its comobidities have a bidirectional relationship, in other 
words, each condition worsens the other. While current treatment modalities for edentulism, 
such as dental implant therapy, are aimed at improving function and esthetics for patients, 
the systemic and oral co-morbidities of edentulism, including diabetes, osteoporosis, as well 
as a lack of sufficient remaining alveolar bone, challenge the immediate and long-term 
success of dental implant therapy. Recently there has been an incorporation of porous 
tantalum metal into titanium dental implants. This new type of dental implant may improve 
dental implant therapy in certain populations. This article therefore aims to review the basic 
science development, advantages and cautions, as well as possible clinical applications of 
the new tantalum metal implants.
Tantalum
Tantalum (Ta) is a rare, highly corrosion resistant transitional metal element with atomic 
number 73. The word tantalum was coined from Tantalus, a Greek mythology figure who 
was eternally punished to stand in a pool of water under a tree with low hanging fruit. When 
Tantalus reached to get the water, the water would recede. And when he reached for the fruit 
the tree branch would move higher.8,9 This “tantalizing” property of Ta was seen by the 
early chemists when Ta was immersed in acids.10 Tantalum, they found, was highly 
unreactive in almost all acids, except hydrofluoric acid and acids containing fluoride and 
sulfur trioxide. Tantalum is a member of the refractory metals group, which are widely used 
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as components in alloys. The Swedish chemist, Anders Gustav Ekebereg, discovered 
Tantalum in 1802.11 Tantalum, in the early years of discovery, was found in its oxide form
—as columbium, which is a combination of columbite and tantalite.12 William Hyde 
Wollaston, an English chemist, showed that both columbite and tantalite are derivatives of 
the same element and kept the name, tantalum.13
Industrial mining and purification of tantalum
Tantalum is often extracted from the mineral, tantalite. It is primarily mined in western 
Australia, and produced as a by-product of tin mining in Thailand and Malaysia and ore 
mining in China, Ethiopia, and Mozambique.14 Extraction of tantalum from naturally 
occurring tantalite is accomplished by gravity separation, which separates components of the 
mixture based on the differences of their specific weights. This is followed by chemical 
separation using hydrofluoric and sulfuric acid solutions and heat. The process will extract 
the oxides of tantalum from its natural cohabitant element, Niobium.15 From there, the 
compound is further purified using liquid extraction of the fluorides. Tantalum fluorides can 
then be extracted by organic solvents and further precipitated with potassium fluoride. Then, 
molten sodium is used to create tantalum powder.14
Because tantalum is a rare element, only making up 1–2 ppm of the Earth’s crust by weight, 
recycling of tantalum oxide is important to maintain supply.15 The main source of material 
for recycling tantalum is waste from capacitors. In 2005, Mineta and Okabe investigated a 
recycling method for tantalum. In the study, they found that sintered tantalum electrodes 
inside capacitor scraps could be collected after oxidation, and high purity Ta2O5 powder 
could be recovered following chemical treatment.16 This process yielded tantalum powder 
with 99 mass% purity.16 Tantalum is extremely inert and resistant to acid corrosion. Only 
hydrofluoric acid and acid solutions containing fluoride and sulfur trioxide can dissolve 
tantalum.14 This inertness is ideal for fabrication of orthopedic implants.17 The inertness and 
biocompatibility of tantalum is a result of tantalum oxides forming on the surface of 
tantalum—similar to titanium and its oxides. Tantalum has two forms of oxide, +5 (Ta2O5) 
and +4 (TaO2). The +5 (Ta2O5) or tantalum pentoxide form is the most stable oxide.18 
Similar to titanium, tantalum is very reactive to oxygen and the oxide layer of tantalum can 
form on the metal surface immediately after the surface is exposed to oxygen. Annealed 
tantalum has great ductility. However, grinding annealed tantalum is very difficult. Because 
tantalum is reactive to oxygen, it cannot be soldered and welding can only be done under 
inert gas environment.14 Tantalum is used in electrodes for pacemakers, devices for nerve 
repair, radiographic markers, and cranioplasty plates.17,19
Production of porous tantalum trabecular metal (PTTM)
Cobalt chromium, titanium alloys, and stainless steel have been the conventional materials 
used for orthopedic implants. With alterations and enhancements including surface coatings 
and porous designs, these materials have shown a high clinical effectiveness. Nevertheless, 
they still have several limitations including low volumetric porosity, relatively high modulus 
of elasticity and low frictional characteristics.17 The development of porous tantalum metal 
has allowed for stronger, more biocompatible orthopedic, craniofacial, and dental implants. 
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The structure of porous tantalum metal affords a high volumetric porosity, a low modulus of 
elasticity, and relatively high frictional characteristics.17
Even though tantalum is highly biocompatible, inert and extremely resistant to corrosion, its 
use in orthopedic implant devices was limited because of the difficulty in manipulating solid 
tantalum. Replacing osseous structure traditionally uses solid materials such as titanium or 
porous materials such as hydroxyapatite (HA) or tricalcium phosphate (TCP). Attempts had 
been made to coat some alloys, such as chrome-cobalt or titanium alloy with HA or TCP. 
However, these attempts in the past failed to mimic the structure of osseous cancellous bone. 
Additionally, there was mechanical failure, resulting from lack of yield strength and 
ductility of the coating materials. It is not until the early 1990s that porous tantalum 
trabecular metal (PTTM) was introduced.20
PTTM, known commercially as Trabecular Metal Material (Zimmer, Trabecular Metal 
Technology, Inc., Parsippany, NJ) is an open-cell porous biomaterial with a structure similar 
to trabecular bone by having three-dimensional dodecahedron repeats (Figure 1a). The open-
cell dodecahedron repeats are fabricated by a foam-like vitreous carbon scaffold,20,21 which 
forms an initial general scaffold and eventually becomes the internal skeleton of the PTTM 
implant device. The vitreous carbon scaffold is then placed in an air sealed chamber. Note 
that unlike the extraction of tantalum from nature, recycled tantalum metal, commonly used 
in industry such as capacitors in computers and cellular phones, is used here in the PTTM 
fabrication process. Tantalum coating of the scaffold is done by chemical vapor diffusion 
process using hydrogen and chlorine gases. The tantalum is evaporated as TaCl2 and the 
tantalum molecules are then deposited onto the scaffold.20–22 PTTM is, therefore, superior 
to other metal implant technologies such as titanium because it has a high degree of 
porosity.21 The vitreous carbon skeleton comprising the trabecular framework of the implant 
can be altered.17 This means that a variety of designs of PTTM may be created, which is 
utilized especially in creating orthopedic implants. Review of the literature on PTTM as an 
orthopedic implant material suggests that this material has great biocompatibility, 
osteoconductivity, bone ingrowth and vascularization in both in vitro/in vivo experiments 
and in human studies.17,23–27 The PTTM allows an implant surface enhancement not only 
for bone ongrowth but also bone ingrowth. PTTM structure allows neovascularization and 
new bone formation directly into the implant. This concept is known as 
“osseoincorporation”.21,23
PTTM-enhanced titanium dental implants
While the PTTM technology has had great success in the orthopedic field for almost two 
decades, the technology has not been applied to dental implants until recently (Figure 1b). 
The designs of modern root-form endosseous implants date back even before the discovery 
of osseointegration by P. I. Branemark in the early 1970s to 1980s.28,29 Branemark 
revolutionized the surgical protocol by controlling the heat generated during implant site 
preparation, using root-form implants, and allowing a certain period of unloading of 
implants for healing. Branemark recognized that heat generated from surgical preparation of 
the implant site needs to be controlled. He experimented with varieties of implants but ended 
up with a root-form titanium implant design, which allows simplicity of implant placement. 
Bencharit et al. Page 4






















In addition, failure of root-form implants only leave a small defect that can be easily 
repaired in most cases. Root-form implants also allow a close proximity of the implant site 
and the implant, which enhances bone healing. While a large part of the original concept of 
Branemark’s osseointegration remains valid, the unloading period for implant healing after 
surgery has been challenged many times.
Since the introduction of the osseointegration concept, there have been two distinct changes 
from the implants Branemark used: first, the internal connection and second, the implant 
surface designs. The implants that were introduced by Branemark had an external hex 
feature. Implant screw loosening and screw fracture demonstrated to be a major problem 
with this design.30 Nowadays almost all implants in the current market have some features 
of internal connection. More importantly, the titanium implants originally used by 
Branemark have a machine-finished surface. Similar to the external hex design, this 
relatively smooth surface design has also disappeared from the market. The smooth machine 
finished surface is often blamed for the peri-implant bone loss originally thought of by 
Branemark’s group as a physiological condition.31 All of the implant surface designs in the 
current market have some features that increase surface roughness in order to obtain a larger 
and more stable osseointegrated bone-implant contact area. Improving the roughness of the 
implant surface has shown to reduce the peri-implant bone loss seen in the original 
Branemark-designed implants. This roughness or coating of implants can be done using 
blasting with various types of grit particles, acid etching, plasma spraying or a combination 
of these techniques.32 Improvement in hydrophilicity or lowering the liquid surface contact 
angle of implant surfaces with roughness or surface coating has also been used.33 In any 
case, these surface roughness technologies often improve the surface contact in the micro- 
and nano-level by reducing the free-energy of the surface and thereby facilitating the 
adsorption of platelets, monocytes and clotting proteins.34 Reducing the free-energy of the 
surface promotes the adherence of platelets that when adsorbed release PDGFs (platelet-
derived growth factors) which are chemotactic and mitogenic for mesenchymal cells and 
osteoblast progenitor cells. This serves to draw cells toward the implant surface. Monocytic 
cells are also among the first to adsorb and the hydrophilic nature of the surface stimulates 
the differentiation into a “M2” cellular phenotype which secretes growth factors facilitating 
would healing and tissue regeneration, rather than the “M1” phenotype which secretes pro-
inflammatory molecules such as TNFa and IL-1b which are catabolic to connective tissue 
metabolism. The M1 phenotype secretes molecules such as FGFs (fibroblast growth factors), 
IGFs (Insulin-like growth factors) and transforming growth factors including bone 
morphogenetic proteins (BMPs) that further attract osteoprogenitor cells, and facilitate rapid 
angioneogenesis and osseous regeneration. While it seems that current implant surface 
treatment improves osteoblastic activity at the implant surface and therefore enhances 
implant-bone contact resulting in lower peri-implant bone loss, it does little to improve the 
surface area and bone ingrowth into the implant.
Recently, PTTM technology was introduced to create a three-dimensional bone ingrowth 
scaffold around dental implants (Figure 1b–c). The PTTM material was added to the middle 
section of the Titanium multi-threaded self-tapping endosseous dental implant (Tapered 
Screw-Vent® Implant. Zimmer Dental Inc.). The apical and cervical sections of this PTTM-
enhanced titanium dental implant retain the screw-type design with a rough surface created 
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by grit-blasting with hydroxyapatite or HA particles (MTX surface, Zimmer Dental Inc). 
The titanium alloy (Ti-6Al-4V grade 5) and the PTTM components of the implant are 
manufactured separately. The cervical portion and the middle core of the titanium alloys are 
milled in one piece. Similarly the apical portion is milled separately. The PTTM sleeve, ~ 2 
mm cylinder, is composed of 2% vitreous carbon core scaffold and 98% tantalum coating. 
The PTTM sleeve is then placed into the middle titanium alloy core and the core is then 
laser welded to the apical portion.22
Advantages of PTTM-enhanced titanium dental implants
The PTTM-enhanced titanium dental implants theoretically provide several advantages over 
other implant designs. The PTTM portion of the implant has an open-cell dodecahedron 
repeat structure which allows for rapid endothelial budding and ingrowth through the 
expanded structure in response to the angiogenic and anabolic growth factor gradient 
produced within the scaffold by the metal surface interacting with the initial blood clot. The 
dimensions of the open structure are designed to accommodate rapid endothelial 
neovascularization which is critical to permit subsequent osteoblast precursor recruitment 
and osteoblastic cell differentiation, growth and matrix secretion.35 This healing granulation 
tissue promotes new osseous tissue formation and bone ingrowth shown to be suitable for 
withstanding immediate and early loading in orthopedic implants.25 Similar to titanium, the 
tantalum layer of PTTM, when oxidized, is highly unreactive, and therefore, biocompatible 
in the body. Tantalum does not exhibit toxicity to surrounding cells, nor does it inhibit local 
cell growth, i.e. osseous ingrowth of surrounding bone. An in vitro study, comparing 
titanium, tanlalum and chromium in osteoblastic differentiation using human mesenchymal 
stem cells, suggests that tatalum has similar biocompatibity to titanium. While titanium 
allows faster cell proliferation, tantalum enhances osteoblastic differentiation process.36 The 
trabecular structure of the porous tantalum metal in PTTM-enhanced titanium dental 
implants can also improve osseointegration simply by increasing bone-implant interface area 
in the three-dimensional manner promoting angiogenesis and mimicking natural osseous 
structure.25 The porous metal structure exhibited by the implants is exceedingly similar to 
that of natural spongy bone and appears to be one the reasons why osseous ingrowth occurs 
so readily. The open cell structure of PTTM is superior to other surface treatment methods 
that attempt to produce porosity of the implant, but does not achieve complete porosity. Pore 
size can also be altered with PTTM to match the surrounding bone.24 However, the 
commercially available PTTM has a standardized pore size thought to be an optimal 
dimension for promoting osseoincorporation37 (Figure 1a). In addition to the advantage of 
trabecular makeup, PTTM exhibits an elastic modulus similar to bone and is mechanically 
superior to other alloys used in dental implants.25 PTTM allows for elastic deformation and 
load distribution. This means it is able to avoid placing local stress on the surface of articular 
cartilage in orthopedic artificial joint. Also, bone resorption is less likely since the stress is 
distributed throughout the structure to the surrounding bone. Harrison et al38 showed that the 
use PTTM in a knee implant prevents resorption of adjacent tibia that contributes to the 
common failure of artificial joints. They further suggested that the similarity in the 
mechanical properties of PTTM and surrounding bone prevents stress shielding and, 
therefore, long-term bone loss. Finally, the PTTM-enhanced titanium dental implants retain 
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most if not all of the advantages of the root-form endosseous self-tapping implants in terms 
of primary stability, ability to be removed and grafted when it fails, and prosthetic/
restorative simplicity. The advantages of high biocompatibility, similar porous structure to 
natural bone, and excellent mechanical properties of PTTM-enhanced titanium dental 
implants may give them an advantage over other dental implants, particularly for patients 
through enhancement of osseointegration, or osseoincorporation.
Potential clinical applications for PTTM-enhanced titanium dental implants
Modern root-form endosseous titanium dental implants are commonly used because of their 
high success rate. However, there are certain case scenarios that show current dental implant 
therapy can be enhanced. First, in the case of poor tissue healing, for instance patients with 
diabetes39,40, osteoporosis41, irradiated bone42,43, and heavy use of tobacco44,45, may 
benefit from this type of implant. Second, when there is insufficient remaining bone 
structure that requires simultaneous bone augmentation or in the newly grafted bone, PTTM 
in orthopedic cases have shown adequate healing of the grafted tissues.20 In the oral cavity, 
PTTM may help in cases that need simultaneous implant placement and horizontal/vertical 
bone augmentation or cases with simultaneous implant placement with sinus augmentation 
or cases with newly grafted sinuses or sockets (Figure 2). Third, PTTM-enhanced titanium 
dental implants may therefore serve as a valuable alternative for patients with bone quality 
type 3 and 4. In subjects with Type 3 or 4 bone or with impaired wound healing due to 
systemic complications, the improved and enlarged surface area that is provided by the 
PTTM collar may result in faster and more robust osseointegration. Fourth, in the normal 
dental implant cases that require immediate provisionalization and loading or sooner 
insertion of permanent prostheses, due to patient’s demand, faster healing time may be 
needed (Figure 3 and 4). PTTM-enhanced titanium dental implants may give patients and 
clinicians another treatment option for immediate placement and loading of implants. While 
we may assume that immediate and early loading of PTTM-enhanced titanium dental 
implants is recommended based on orthopedic literature, there is currently no study on such 
topics. Prospective clinical trials will be needed to examine if this type of implants is really 
superior to conventional titanium dental implants.
Potential problems with PTTM-enhanced titanium dental implants
While PTTM implants have been used widely and successfully as orthopedic implants, the 
application of PTTM in the oral cavity remains limited until now. The major concern for this 
type of implant is perhaps the uniqueness of the oral environment. Unlike most orthopedic 
surgical sites, the oral cavity is a complex unsterile field, which can harbor over 500 
different bacterial species. Various microorganisms live in the oral cavity. The interactions 
of the host tissue, saliva, and microorganisms can make it difficult to predict how PTTM 
implants would react to this complex environment. Titanium implants can be susceptible to 
infection because of: (1) surface biofilm and (2) compromised immune ability at implant 
tissue interface.46 While tantalum itself is similar to titanium in that it is highly 
biocompatible and corrosion resistant, the interactions with oral fluid, oral microbes and 
biofilm of the PTTM portion are not known. The concern can extend into the case of peri-
implantitis and how we may treat it in the case of PTTM-enhanced titanium dental implant. 
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This concern will remain unanswered until we see the results of long-term studies of these 
implants. It is our anecdotal opinion that if the peri-implant bone loss extends into the 
PTTM portion of the implant, removal of the implant will be needed. Moreover, implant 
removal, grafting and subsequently a new implant placement may be indicated as a 
treatment of choice for peri-implantitis for this type of implants. Finally, a mechanical 
concern has been raised around PTTM-enhanced titanium dental implants. Due to implant 
manufacturing, the connection between the relatively small titanium core/PTTM in the 
middle-third portion and the apical titanium portion (Figure 1c) may be prone to fracture 
especially if they are placed in hard bone (type 1) with in appropriate high torque. These 
implants are however recommended for bone that are relatively soft (type 3 or 4). The 
fracture of implants during insertion may therefore not be a major issue in soft bone.
Conclusion
Development of PTTM-enhanced titanium dental implants combined conventional titanium 
implant design and instrumentation with PTTM technology. This theoretically allows for 
true enhancement of osseointegration in a three-dimensional manner, which may be a major 
breakthrough compared with the current focus on titanium implant surface technologies. 
Based on assumptions from orthopedic clinical studies, this type of implant may be 
indicated in poor healing situations, immediate/early loading of implants, and missing 
osseous structure requiring simultaneous implant placement and bone grafting. The 
uniqueness of the oral cavity, in particular the host-oral microbial interaction, is a concern. 
The extent and aggression of peri-implantitis in this type of implant is not known. 
Prospective longitudinal studies are clearly needed, as well as a focus on biomaterial 
research in humans in the oral cavity. In the meantime, clinicians will need to use their own 
judgment with careful case selection criteria until the research proves otherwise.
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Figure 1. Porous Tantalum Trabecular Metal (PTTM) Enhanced Titanium Dental Implants
A) PTTM structure, B) The overall structure of a PTTM-enhanced titanium dental implant 
with cervical smooth titanium metal tissue collar, and C) the structure of a PTTM-enhanced 
titanium dental implant with total rough titanium surface demonstrating the cross-sectional 
of the middle-third of the implant that has outer layer of PTTM and titanium core
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Figure 2. Placement of the implant with simultaneous osteotome sinus augmentation
A 78-year-old female presented with missing teeth from her right canine to first molar (2a). 
To minimize healing time and number of surgical visits, we performed osteotome sinus 
augmentation and placed a 4.7 mm × 13 mm PTTM-enhanced titanium dental implants 
(Trabecular Metal Dental Implants, Zimmer Dental Inc) in the first molar site. Conventional 
titanium implant, 4.1 mm × 11.5 mm tapered threaded implant (Tapered Screw-Vent, 
Zimmer Dental Inc) was placed in the canine site (2b–d).
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Figure 3. Immediate loading of a single tooth implant
A 79-year-old female presented with a fractured maxillary right second premolar. The tooth 
was extracted and the socket was grafted with demineralized freeze-dried allograft and 
demineralized bone matrix (Puros Demineralized Bone Matrix, Zimmer Dental Inc). Four 
months after the extraction, a 4.7 mm × 11.5 mm PTTM-enhanced titanium dental implant 
(Trabecular Metal Dental Implant, Zimmer Dental Inc) was placed using flapless procedure. 
The implant was immediately restored using a screw-retained provisional abutment and 
bisacryl composite resin material (Integrity, Dentsply).
Bencharit et al. Page 13






















Figure 4. Early loading of an implant-retained overdenture
A 49-year-old female presented with chief complaint that her mandibular acrylic partial 
denture was not stable and she had hard time chewing. Her existing denture was used as a 
radiographic and later as a surgical guide (4a). In the mandibular canine areas bilaterally, a 
4.1 × 11.5 mm PTTM-enhanced titanium dental implants (Trabecular Metal Dental 
Implants, Zimmer Dental Inc) was placed using flapless procedure (4b). Overdenture 
abutments (Locator, Zest Anchors) were immediately placed (4c). A denture tissue 
conditioner (Coe Comfort, GC America) was used to reline the denture in the area directly 
coronal to the implants. Due to a family issue, the patient had to leave the country three 
weeks after the surgery. Locator attachments were then added to the denture three weeks 
after the implants were placed (4d). The patient in her home country will have her remaining 
teeth extracted due to limited periodontal support and receive a mandibular implant-
supported overdenture.
Bencharit et al. Page 14
Clin Implant Dent Relat Res. Author manuscript; available in PMC 2015 December 01.
N
IH
-P
A
 A
uthor M
anuscript
N
IH
-P
A
 A
uthor M
anuscript
N
IH
-P
A
 A
uthor M
anuscript
